Chemours CO Form 4 insider transactions

NYSE
Gerardo Calderon, a Chemours executive, reported a transaction involving the withholding of shares to cover tax obligations on vested stock units.
NYSE
Denise Dignam, CEO of Chemours, reports a transaction involving common stock to cover tax obligations on vesting restricted stock units and dividend equivalent units.
NYSE
Matthew S. Abbott, SVP, Chief Enterprise Transformation Officer of Chemours Co, reported disposing of 453 shares of common stock on August 1, 2024, to cover tax obligations related to vesting restricted stock units and dividend equivalent units.
NYSE
Kristine M Wellman, SVP, GC & Corp. Secretary of Chemours Co, reports the acquisition of common stock and stock options.
NYSE
Alvenia Scarborough, SVP Corp Communications & CBO of Chemours Co, reports the acquisition of common stock and stock options.
NYSE
Diane I. Picho, Interim President of Titanium Technologies at Chemours Co, reports acquiring shares and stock options on May 8, 2024.
NYSE
Joseph T. Martinko, President of Thermal & Specialized Solutions at Chemours Co, reports the acquisition of stock and option awards.
NYSE
Gerardo Familiar Calderon, a Chemours Co executive, acquired shares and stock options on May 8, 2024, according to a recent SEC filing.
NYSE
Chemours CEO Denise Dignam reports the acquisition of restricted stock units and stock options.
NYSE
Senior Vice President of People at Chemours Co, Charles Ron Christopher, reports acquiring shares and stock options.
NYSE
Interim CFO of Chemours, Matthew Abbott, reports the acquisition of common stock and stock options.
NYSE
Director Pamela Fletcher acquired 1,454 shares of Chemours Co common stock on May 8, 2024, through deferred stock units.
NYSE
Alvenia Scarborough, SVP Corp Communications & CBO of Chemours, reports acquisition and disposal of common stock related to vesting of performance share units.
NYSE
Interim CFO of Chemours Co, Matthew S. Abbott, reports acquisition and disposal of common stock due to vesting of performance share units and tax obligations.
NYSE
Chemours CEO Denise Dignam reports the vesting of performance share units and shares withheld for tax obligations.
NYSE
Alvenia Scarborough, SVP Corp Communications & CBO of Chemours Co, files an amended SEC Form 4 to correct the amount of securities beneficially owned following reported transactions.
NYSE
Kristine M. Wellman, SVP, GC & Corp. Secretary of Chemours Co, reports the withholding of 1,726 common stock shares to cover tax obligations on vesting restricted stock units dividend equivalent units.
NYSE
Alvenia Scarborough, SVP Corp Communications & CBO of Chemours Co, reports the withholding of shares to cover tax obligations on vesting restricted stock units.
NYSE
Joseph T. Martinko, President of Thermal & Specialized Solutions at Chemours Co, reported disposing of 795 shares of common stock on March 1, 2024, to cover tax obligations.
NYSE
Gerardo Familiar Calderon, a Chemours executive, disposed of shares to cover tax obligations related to vesting restricted stock units.
NYSE
Interim CEO of Chemours, Denise Dignam, reports a transaction involving the withholding of common stock to cover tax obligations related to vesting restricted stock units.
NYSE
Senior Vice President of People at Chemours Co, Charles Ron Christopher, reports changes in beneficial ownership due to tax obligations on vesting restricted stock units dividend equivalent units.
NYSE
Interim CFO of Chemours Co., Matthew Abbott, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.